To accelerate breakthroughs, the Damon Runyon Foundation provides today's best young scientists with funds to pursue innovative cancer research.
- Today’s Promising Areas of Cancer Research
- What is Cancer?
- A Broken Pipeline?
A Generation of Science at Risk
- ARISE Report
Early Career Scientists and High-Risk, High Reward Research - American Academy of Arts and Sciences
- Why We’re Losing the War on Cancer (And How To Win It)
Clifton Leaf - Fortune Magazine
August 4, 2010 > Molecular diagnostic technology using single cells
Hong Wu, MD, PhD (Damon Runyon Fellow ‘92-‘95, Former Sponsor) and a team of researchers at the University of California, Los Angeles, have developed a new technology that can measure signaling pathway levels in a single cell from tissues, including brain tumors. The new technology, microfluidic image cytometry (MIC), combines microfluidics and microscopy-based cell imaging. These molecular “fingerprints” are a new advance in diagnostics that could ultimately help physicians predict patient prognosis and guide personalized treatment. This study was published in the journal Cancer Research.